Mavacamten: A Game-Changer for Teens with Heart Obstruction from Hypertrophic Cardiomyopathy Recent studies reveal mavacamten reduces heart obstruction in adolescents with hypertrophic cardiomyopathy, offering a new hope for treatment.

Mavacamten: A Game-Changer for Teens with Heart Obstruction from Hypertrophic Cardiomyopathy #USA #Philadelphia #Children's_Hospital #Hypertrophic_Cardiomyopathy #Mavacamten

Braveheart Bio Announces Participation in Major Healthcare Conference for Future Innovations Braveheart Bio will participate in the TD Cowen 46th Annual Health Care Conference on March 2-4, 2026, in Boston to engage with investors.

Braveheart Bio Announces Participation in Major Healthcare Conference for Future Innovations #USA #San_Francisco #Hypertrophic_Cardiomyopathy #TD_Cowen #Braveheart_Bio

Braveheart Bio Strengthens Leadership Amid Global Phase 3 Development for Hypertrophic Cardiomyopathy Braveheart Bio has made key senior appointments to enhance its scientific and operational expertise as it gears up for a global Phase 3 trial in hypertrophic cardiomyopathy.

Braveheart Bio Strengthens Leadership Amid Global Phase 3 Development for Hypertrophic Cardiomyopathy #United_States #San_Francisco #Hypertrophic_Cardiomyopathy #Braveheart_Bio #BHB-1893

Braveheart Bio to Showcase Novel Therapies at J.P. Morgan Healthcare Conference Braveheart Bio is set to present its innovations in cardiac treatment at the prestigious J.P. Morgan Healthcare Conference, anticipated for January 2026.

Braveheart Bio to Showcase Novel Therapies at J.P. Morgan Healthcare Conference #United_States #San_Francisco #Hypertrophic_Cardiomyopathy #Braveheart_Bio #BHB-1893

Edgewise Therapeutics Reports Positive Progress in EDG-7500 Hypertrophic Cardiomyopathy Trials Edgewise Therapeutics announces positive updates on EDG-7500's Phase 2 clinical trials for hypertrophic cardiomyopathy, showcasing favorable safety results.

Edgewise Therapeutics Reports Positive Progress in EDG-7500 Hypertrophic Cardiomyopathy Trials #USA #Boulder #Hypertrophic_Cardiomyopathy #Edgewise_Therapeutics #EDG-7500

Understanding Hypertrophic Cardiomyopathy: Importance of Family Heart History Learn why knowing your family’s heart history is crucial for identifying hypertrophic cardiomyopathy and preventing sudden cardiac death, especially in young athletes.

Understanding Hypertrophic Cardiomyopathy: Importance of Family Heart History #United_States #Mission,_Kansas #Hypertrophic_Cardiomyopathy #American_Heart_Association #Heart_Awareness

The Challenges of Accessing Treatment for Hypertrophic Cardiomyopathy Patients A recent report unveils significant barriers faced by hypertrophic cardiomyopathy patients in accessing vital treatments, highlighting the need for improved care.

The Challenges of Accessing Treatment for Hypertrophic Cardiomyopathy Patients #United_States #Washington #Health_Care #Hypertrophic_Cardiomyopathy #Patient_Access